» Articles » PMID: 36289716

Plasma and Peritoneal Poly (ADP-Ribose) Polymerase Levels in Patients with Endometriosis

Abstract

The evidence of poly (ADP-ribose) polymerase (PARP) association with the immune response could be coherent with the immunological theory of endometriosis and suggests the possibility of a new research direction. The aim of the study was to evaluate the levels of PARP in plasma and peritoneal fluid of patients with and without endometriosis. It was a multicenter, cross-sectional study. Plasma and peritoneal fluid samples were collected from patients with and without endometriosis during planned laparoscopic procedures in eight clinical centers. In total, 84 samples of plasma and 84 samples of the peritoneal fluid were included in the final analyses. Double-antibody sandwich enzyme-linked immunosorbent assay was performed in order to assess levels of PARP in collected samples. No statistically significant differences regarding the detected levels of PARP in plasma and peritoneal fluid comparing patients with and without endometriosis were observed. Patients with a history of infertility had significantly higher plasma PARP concentrations ( = 0.04). We have not observed the potential role of PARP concentration levels in plasma nor peritoneal fluid as an endometriosis biomarker. We have determined an association between a higher plasma PARP concentration and a history of infertility.

Citing Articles

Is the leptin/BMI ratio a reliable biomarker for endometriosis?.

Zygula A, Sankiewicz A, Sakowicz A, Dobrzynska E, Dakowicz A, Manka G Front Endocrinol (Lausanne). 2024; 15:1359182.

PMID: 38567305 PMC: 10985179. DOI: 10.3389/fendo.2024.1359182.


Investigation of the Changes in Concentrations of Vitamin D-Binding Protein and Lactoferin in Plasma and Peritoneal Fluid of Patients with Endometriosis.

Lisowska-Myjak B, Skarzynska E, Wrobel M, Manka G, Kiecka M, Lipa M Int J Mol Sci. 2023; 24(9).

PMID: 37175534 PMC: 10178223. DOI: 10.3390/ijms24097828.


An Array SPRi Biosensor for the Determination on PARP-1 in Blood Plasma.

Zielinska Z, Oldak L, Kacperczyk-Bartnik J, Koc-Zorawska E, Zorawski M, Laudanski P Biomedicines. 2023; 11(2).

PMID: 36831138 PMC: 9953221. DOI: 10.3390/biomedicines11020602.


Plasma and Peritoneal Fluid Fibronectin and Collagen IV Levels as Potential Biomarkers of Endometriosis.

Warzecha D, Zalecka J, Manka G, Kiecka M, Lipa M, Spaczynski R Int J Mol Sci. 2022; 23(24).

PMID: 36555313 PMC: 9778765. DOI: 10.3390/ijms232415669.

References
1.
Barreta A, Sarian L, Ferracini A, Bastos Eloy Costa L, Mazzola P, de Angelo Andrade L . Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis. Hum Pathol. 2018; 85:72-81. DOI: 10.1016/j.humpath.2018.10.028. View

2.
Koninckx P, Kennedy S, Barlow D . Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update. 1999; 4(5):741-51. DOI: 10.1093/humupd/4.5.741. View

3.
Talebi H, Farahpour M, Hamishehkar H . The effectiveness of Rutin for prevention of surgical induced endometriosis development in a rat model. Sci Rep. 2021; 11(1):7180. PMC: 8010059. DOI: 10.1038/s41598-021-86586-4. View

4.
. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67(5):817-21. DOI: 10.1016/s0015-0282(97)81391-x. View

5.
Laudanski P, Szamatowicz J, Oniszczuk M . Profiling of peritoneal fluid of women with endometriosis by chemokine protein array. Adv Med Sci. 2007; 51:148-52. View